Thus, we performed quantitative real-time PCR (qRT-PCR) analyses, which confirmed that CTSH, CTSO, CTSF, CTSK, CTSS, CTSV and CTSB were significantly downregulated in glioma cells treated with ar-turmerone (Figure 4C). This evidence concerns the gene CTSO and central nervous system cancer.